financetom
Business
financetom
/
Business
/
Natural Alternatives Q4 Loss Widens, Sales Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Natural Alternatives Q4 Loss Widens, Sales Rise
Sep 23, 2025 2:11 PM

04:48 PM EDT, 09/23/2025 (MT Newswires) -- Natural Alternatives International ( NAII ) reported a Q4 net loss late Tuesday of $1.20 per diluted share, wider than a loss of $0.32 a year earlier.

Net sales for the quarter ended June 30 were $33.9 million, up from $29.5 million a year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Peru copper output falls nearly 5% in November on Antamina slide
Peru copper output falls nearly 5% in November on Antamina slide
Jan 15, 2025
LIMA, Jan 15 (Reuters) - Copper output in Peru dipped in November as production from the Antamina mine slid, according to data from the Andean nation's energy and mines ministry published on Wednesday. Peru is the world's third-largest miner of the key industrial metal. Overall, national copper production fell 4.6% in November compared to the year-ago month to settle at...
Market Chatter: US Government to Restrict Biotechnology Equipment Exports to China
Market Chatter: US Government to Restrict Biotechnology Equipment Exports to China
Jan 15, 2025
12:28 PM EST, 01/15/2025 (MT Newswires) -- The US government is restricting exports of biotechnology equipment and related technology to China over national security concerns, Reuters reported Wednesday. According to the report, the US Department of Commerce is imposing these export controls because of their possible use in human performance enhancement, brain-machine interfaces, biologically-inspired synthetic materials, and possibly biological weapons....
AbbVie plans to 'commit less capital' towards psychiatric drugs, CEO says
AbbVie plans to 'commit less capital' towards psychiatric drugs, CEO says
Jan 15, 2025
Jan 15 (Reuters) - AbbVie ( ABBV ) will commit less capital towards experimental medicines for psychiatric disease, CEO Robert Michael said at an industry conference on Wednesday. The remarks come months after its experimental schizophrenia drug failed in two mid-stage studies. Committing that much capital on early data, I'd say we would certainly rethink that in psych, said CEO...
American Water, Calgon Carbon Enter PFAS Treatment Supply Contract
American Water, Calgon Carbon Enter PFAS Treatment Supply Contract
Jan 15, 2025
12:27 PM EST, 01/15/2025 (MT Newswires) -- American Water Works ( AWK ) signed a nine-year exclusive contract with Calgon Carbon to provide activated carbon products and services to treat per- and polyfluoroalkyl substances, or PFAS, in drinking water, the companies said Wednesday. Under the partnership, Calgon will provide granular activated carbon, equipment and reactivation services to more than 50...
Copyright 2023-2026 - www.financetom.com All Rights Reserved